![Craig M. van de Mark](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Craig M. van de Mark
Director/Miembro de la Junta en ZZ Biotech LLC .
Perfil
Craig M.
van de Mark currently works as a Director & Vice President-Legal at ZZ Biotech LLC.
Cargos activos de Craig M. van de Mark
Empresas | Cargo | Inicio |
---|---|---|
ZZ Biotech LLC
![]() ZZ Biotech LLC BiotechnologyHealth Technology ZZ Biotech LLC operates as a clinical stage company. It develops biologic treatments for ischemic stroke and other neurological diseases and wound healing applications including the treatment of diabetic foot ulcers. The firm mainly focuses on developing 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Institute. The company was founded by Selim Zilkha and Berislav V. Zlokovic in 2006 and is headquartered in Houston, TX. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
ZZ Biotech LLC
![]() ZZ Biotech LLC BiotechnologyHealth Technology ZZ Biotech LLC operates as a clinical stage company. It develops biologic treatments for ischemic stroke and other neurological diseases and wound healing applications including the treatment of diabetic foot ulcers. The firm mainly focuses on developing 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Institute. The company was founded by Selim Zilkha and Berislav V. Zlokovic in 2006 and is headquartered in Houston, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Craig M. van de Mark